The page is the record's research on the issuer — no analyst, no rating, no view. # Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing The issuer is Ultragenyx Pharmaceutical Inc., listed on NASDAQ under ticker RARE, ISIN US90400D1081, LEI 529900EV44GVDN1DCX77. The security type is Corporate, the segment is not on the record, the sector is 2834 Pharmaceutical Preparations, and the jurisdiction is United States, Delaware. The issuer is listed and not halted. ## The disclosure read The record holds 98 filings in the window 2025-11-08 to 2026-11-08, across 59 filing days. The median gap between filing days is 3.5 days. The latest filing is dated 2026-11-04, is of type results, and falls 4 days before the record date. The NASDAQ median is 52 filings, a median cadence gap of 6.0 days and a median latency of 5.0 days across 4,359 issuers. The 2834 Pharmaceutical Preparations sector median is 63.0 filings, a median cadence gap of 6.0 days and a median latency of 4.0 days across 526 issuers. Filings by type are: directors' dealings 40, regulatory filing 30, corporate news 15, results 8, AGM/EGM 3, director change 1, takeover 1. ## Auditor The auditor of record is not on the record, as the latest annual report cover carries no dei:AuditorName tag, and its location is not on the record. The record holds no auditor changes. ## Events and halts The record holds no listing, delisting or name change lines. The domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The halt flag is listed, not halted. ## Orderability The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04. ## Coverage No research houses were found on the issuer's investor-relations page. ## Open research No openly published research notes were found. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The issuer's years sealed are 2021, 2022, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12. ## Sources 8 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://mapping.gleif.org/api/v2/isin-lei/latest (identity.isin) - https://data.sec.gov/submissions/CIK0001515673.json (identity.jurisdiction) - https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei) - https://mcp.us-cm-kg.ai/events/NASDAQ/RARE (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://mcp.us-cm-kg.ai/record/NASDAQ/RARE (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/RARE · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp